Lancet Robotics Secures Tens of Millions in Angel Funding to Advance Orthopedic Surgical Robot Commercialization

VCBeat has learned that orthopedic surgical robot company Lancet Robotics has completed tens of millions of yuan in angel-round financing, with investors including Yuansheng Venture Capital and Qianhai Fund of Funds. Shenzhen Lancet Robotics Co., Ltd., founded in 2020, is engaged in the research and development of robotic systems for orthopedic joint replacement surgeries. Its hip replacement surgical robot is primarily designed to assist clinicians in performing precise, safe, and visualized joint replacement procedures, thereby improving the accuracy of prosthetic implantation, reducing postoperative revision rates, and mitigating complications associated with inaccurate prosthetic positioning in conventional surgeries.

Robot-assisted joint replacement surgery represents a growing trend in orthopedic procedures. In the United States, more than 800 hospitals have adopted robotic systems for joint replacement, achieving a penetration rate exceeding 50%. In contrast, the development of such robotic systems in China remains in its early stages.

This medical-engineering integrated application represents the future of minimally invasive surgery. The project team has accumulated years of technical expertise, possessing independently developed core underlying control algorithms for robotics and medical imaging algorithms. These innovations enable intelligent preoperative surgical planning, precise intraoperative navigation and positioning, and real-time haptic feedback control of surgeons’ operative maneuvers.

The company’s core team possesses years of accumulated engineering expertise in the field of surgical robotics, with senior orthopedic specialists deeply involved in product development and clinical collaboration. Founder Huang Zhijun holds a bachelor’s degree in Physics from the University of Science and Technology of China and a master’s degree in Computer Science from Tsinghua University. He has previously engaged in R&D management at renowned enterprises such as Siemens Healthineers and Hikvision, as well as at start-ups.

The proceeds from this round of financing will be used for the clinical registration of joint replacement surgical robot products and the research and development of intelligent surgical solutions.